Point72 Asset Management
NRSN icon

Point72 Asset Management’s NeuroSense Therapeutics NRSN Stock Holding History

Point72 Asset Management’s Portfolio NRSN Stock Details NRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$149K – 2044
2023
Q2 		$149K Buy
+100,000
New +$149K ﹤0.01% 989